This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Innocent Until Proven Guilty

Desmond A Schatz, MD; Noel K. Maclaren, MD

JAMA. 1996;276(8):647-648.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Insulin-dependent diabetes mellitus (IDDM) is a lifelong affliction that affects large numbers of children and adults worldwide.¹ At least 1 in 300 Americans will ultimately develop the disease. Despite advances in insulin purity and delivery, ease of home blood glucose monitoring, and the encouraging results of the Diabetes Control and Complications Trial,² IDDM is still associated with an unacceptably high morbidity and mortality. Thus, IDDM is a huge financial burden to affected individuals and their families as well as to society. The total cost of diabetes in the United States currently exceeds $100 billion per year, with a disproportionately large share accounted for by the 10% to 15% of patients with IDDM.³ Therefore, research aimed at the prevention of IDDM is imperative. The identification and elimination of possible causative agents of the disease would have profound influence on the increasing worldwide incidence of IDDM. Some contend that . . . [Full Text PDF of this Article]

Author Affiliations
From the Departments of Pediatrics (Drs Schatz and Maclaren) and Pathology and Laboratory Medicine (Dr Maclaren), University of Florida College of Medicine, Gainesville.

Footnotes
Reprints: Noel K. Maclaren, MD, Department of Pathology and Laboratory Medicine, University of Florida College of Medicine, Box 100296 JHMHC, Gainesville, FL 32610.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?